Kowa Pharmaceuticals America

Kowa Pharmaceuticals America is a specialty pharmaceutical company focused on the commercialization of products in the cardiovascular and pain management therapeutic areas. A subsidiary of the Japanese multinational Kowa Company, Ltd., the company is best known for its flagship product Livalo (pitavastatin), a statin used for the treatment of primary hyperlipidemia and mixed dyslipidemia. Kowa also markets Seglentis, a co-crystal formulation of celecoxib and tramadol for the treatment of acute pain in adults. The company maintains a strong sales and marketing presence in the United States, leveraging its parent company's global research and manufacturing capabilities to bring innovative therapies to the American market.